Études et publications

EPLS a réalisé de nombreuses études sous l’égide du Ministère des Affaires Etrangères Français, de la Communauté Européenne, et de l’Organisation Mondiale de la Santé (OMS). Depuis 1992, EPLS a réalisé plus de 50 programmes de recherche appliquée dans la vallée du fleuve, dont les résultats ont donné lieu à près de 100 publications dans des revues scientifiques et médicales internationales à comité de lecture.

Publications

Implication of Bulinus truncatus in the transmission of urinary schistosomiasis in Senegal, West Africa

Sène M, Southgate VR, de Clercq D, Ly A, Vercruysse J.

Annals of tropical medicine and parasitology, 2002, 96(2):175-80 (PMID : 12080978)

Studies on the compatibility between Bulinus truncatus and Schistosoma haematobium from various areas in the Senegal River basin (SRB) were carried out, to investigate the role of B. truncatus in the epidemiology of urinary schistosomiasis in Senegal. The results show that B. truncatus from the Lower Valley is not compatible with S. haematobium from the Middle Valley. Interestingly, the study reveals that B. truncatus from the Upper Valley is compatible with S. haematobium from the same area, and that S. haematobium from the Middle Valley is compatible with B. truncatus from the Lower Valley. Bulinus truncatus naturally infected with S. haematobium have been collected from the Upper Valley of the SRB. These results indicate that B. truncatus is involved in the urinary schistosomiasis in Senegal.

lire la suite..

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

Sturrock RF, Davis A.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002, 96(1):10 (PMID : 11925983)

lire la suite..

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

De Clercq D, Vercruysse J, Kongs A, Verlé P, Dompnier JP, Faye PC.

Acta tropica, 2002, 82(1):61-6 (PMID : 11904104)

Praziquantel is the current mainstay for morbidity control of schistosomiasis. Artemisinin and its derivatives, widely used for the treatment of malaria, also display antischistosomal properties. The present study is an effort to assess the therapeutic efficacy of artesunate, an artemisinin derivative, in Schistosoma haematobium infections in a human population. The efficacy of artesunate and praziquantel were comparatively studied in primary schoolchildren from two villages, Lampsar (n=180) and Makhana (n=108), located along the Lampsar river in the delta of the Senegal River Basin in Northern Senegal (West Africa). In each village, half of the infected children were treated with a single oral dose of 40 mg/kg praziquantel and half with artesunate following the recommended malaria monotherapy regimen. For both drugs, cure and egg count reduction rates were, without apparent explanation, higher in Makhana than in Lampsar. In both villages, high and nearly comparable egg count reduction rates were obtained with both drugs at each follow-up after treatment (5, 12 and 24 weeks) in the heavy infected group of children (>50 eggs/10 ml of urine). No major adverse effects were observed. The results demonstrate that artesunate is effective against S. haematobium, but the results obtained with praziquantel were consistently better.

lire la suite..

< Précédent 123456789101112131415161718 Suivant >